Organovo (ONVO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Organovo (ONVO)

ONVO 2.360

-12.6%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: caly	3/26/2012 4:58:46 PM
	Read Replies (1) of 171

NIH grant received on 3/19/2012 sec.gov NIH Grant On March 19, 2012, the Company was awarded a $290,053 grant by the National Institutes of Health (the “NIH”) to support the Company’s development of functional human liver tissue utilizing its proprietary NovoGen three-dimensional bioprinting technology.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext